Access the full text.
Sign up today, get DeepDyve free for 14 days.
L. Wilke, L. Mccall, K. Posther, Pat Whitworth, D. Reintgen, A. Leitch, S. Gabram, A. Lucci, C. Cox, K. Hunt, J. Herndon, A. Giuliano (2006)
Surgical Complications Associated With Sentinel Lymph Node Biopsy: Results From a Prospective International Cooperative Group TrialAnnals of Surgical Oncology, 13
M. Noguchi (2010)
Axillary reverse mapping for breast cancerBreast Cancer Research and Treatment, 119
I. Bedrosian, G. Babiera, E. Mittendorf, H. Kuerer, L. Pantoja, K. Hunt, S. Krishnamurthy, F. Meric-Bernstam (2010)
A phase I study to assess the feasibility and oncologic safety of axillary reverse mapping in breast cancer patientsCancer, 116
D. Blanchard, J. Donohue, C. Reynolds, C. Grant (2003)
Relapse and morbidity in patients undergoing sentinel lymph node biopsy alone or with axillary dissection for breast cancer.Archives of surgery, 138 5
C. Nos, Gabriel Kaufmann, K. Clough, M. Collignon, E. Zerbib, P. Cusumano, F. Lécuru (2008)
Combined Axillary Reverse Mapping (ARM) Technique for Breast Cancer Patients Requiring Axillary DissectionAnnals of Surgical Oncology, 15
Robert Mansel, L. Fallowfield, M. Kissin, A. Goyal, Robert Newcombe, J. Dixon, C. Yiangou, K. Horgan, N. Bundred, I. Monypenny, D. England, M. Sibbering, Tholkifl Abdullah, L. Barr, U. Chetty, D. Sinnett, A. Fleissig, D. Clarke, P. Ell (2006)
Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial.Journal of the National Cancer Institute, 98 9
G. Sakorafas, G. Peros, L. Cataliotti, G. Vlastos (2006)
Lymphedema following axillary lymph node dissection for breast cancer.Surgical oncology, 15 3
M. Leidenius, M. Leivonen, M. Leivonen, J. Vironen, K. Smitten (2005)
The consequences of long‐time arm morbidity in node‐negative breast cancer patients with sentinel node biopsy or axillary clearanceJournal of Surgical Oncology, 92
B Lesieur C Nos (2007)
Blue dye injection in the arm in order to conserve the lymphatic drainage of the arm in breast cancer patients requiring an axillary dissectionAnn Surg Oncol, 14
M. Noguchi, M. Yokoi, Y. Nakano (2010)
Axillary reverse mapping with indocyanine fluorescence imaging in patients with breast cancerJournal of Surgical Oncology, 101
T. Britton, C. Solanki, S. Pinder, P. Mortimer, A. Peters, A. Purushotham (2009)
Lymphatic drainage pathways of the breast and the upper limbNuclear Medicine Communications, 30
M. Thompson, S. Korourian, R. Henry-Tillman, L. Adkins, S. Mumford, K. Westbrook, V. Klimberg (2007)
Axillary Reverse Mapping (ARM): A New Concept to Identify and Enhance Lymphatic PreservationAnnals of Surgical Oncology, 14
M. Noguchi, K. Miwa, T. Michigishi, K. Yokoyama, H. Nishijima, T. Takanaka, H. Kawashima, Shinobu Nakamura, H. Kanno, A. Nonomura (1997)
The role of axillary lymph node dissection in breast cancer managementBreast Cancer, 4
K. Ikeda, Y. Ogawa, H. Komatsu, Y. Mori, A. Ishikawa, Takayoshi Nakajima, Go Oohira, S. Tokunaga, H. Fukushima, Takeshi Inoue (2012)
Evaluation of the metastatic status of lymph nodes identified using axillary reverse mapping in breast cancer patientsWorld Journal of Surgical Oncology, 10
A. Haid, R. Köberle-Wührer, M. Knauer, Judit Burtscher, H. Fritzsche, W. Peschina, Z. Jasarevic, M. Ammann, K. Hergan, H. Sturn, G. Zimmermann (2002)
Morbidity of Breast Cancer Patients Following Complete Axillary Dissection or Sentinel Node Biopsy Only: A Comparative EvaluationBreast Cancer Research and Treatment, 73
V. Klimberg (2008)
Blue Dye Injection in the Arm in Order to Conserve the Lymphatic Drainage of the Arm in Breast Cancer Patients Requiring an Axillary DissectionBreast Diseases: A Year Book Quarterly, 19
R. Ponzone, N. Cont, F. Maggiorotto, E. Cassina, P. Mininanni, N. Biglia, P. Sismondi (2009)
Extensive nodal disease may impair axillary reverse mapping in patients with breast cancer.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 27 33
C. Boneti, S. Korourian, Zuleika Diaz, C. Santiago, S. Mumford, L. Adkins, V. Klimberg (2009)
Scientific Impact Award: Axillary reverse mapping (ARM) to identify and protect lymphatics draining the arm during axillary lymphadenectomy.American journal of surgery, 198 4
Suk-Bok Kang, Junjeong Choi, Jeon Yeejin, S. Lee, Y. Bae (2009)
Preservation of lymphatic drainage from arm in breast cancer surgery: is it safe?.Cancer Research, 69
Abstract The axillary reverse mapping (ARM) technique has been described as an attempt to map and preserve the upper extremity lymphatic drainage during axillary lymph node dissection (ALND) and/or SLNB. This technique is based on the hypothesis that the lymphatic pathway from the upper extremity is not involved by metastasis from primary breast cancer. The ARM node/s however, has been found, in various studies, to be involved with metastatic foci in patients with extensive axillary lymph node metastases. Therefore, the oncological safety of this procedure has not yet been determined. In this pilot study, we assessed the ARM node intraoperatively for various parameters and compared it to final HPR, to try and determine the oncologic safety of preserving the ARM node. Seventy-two breast cancer patients were screened for this prospective pilot study which was planned to recruit 20 patients. The study was initiated on May 2014, 20 patients were recruited till July 2015. Eligibility criterion was as follows: patients requiring primary axillary lymph node dissection based on a clinically positive axilla. Forty-five patients were ineligible because they had either received neoadjuvant chemotherapy or underwent previous axillary surgery or axillary radiation (exclusion criteria). Seven patients refused to give consent. ARM node identification rate was 75%. The most common location of the ARM node was lateral to the latissimus dorsi pedicle (42.10%), none of them being malignant. None of the oval or firm nodes were malignant. Tumor deposits were identified in 13%. Fine-needle aspiration cytology (FNAC) had 100% specificity, 94.4% negative predictive value, 100% positive predictive value, and 50% sensitivity. ARM is feasible using blue dye alone, with an acceptable identification rate. Location, consistency, and intraoperative FNAC of the ARM node, put together, may be reliable parameters to predict involvement of the ARM node with metastasis.
Indian Journal of Surgical Oncology – Springer Journals
Published: Jun 1, 2017
Keywords: surgical oncology; oncology; surgery
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.